ROBO Global Healthcare Technology and Innovation ETF Rating $30.45 +0.11 (+0.36%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$30.44 -0.01 (-0.03%) As of 08/29/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock ROBO Global Healthcare Technology and Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HTEC Aggregate RatingModerate Buy 2.70Holdings in HTEC have an aggregate rating of Moderate Buy based on 338 analyst ratings issued in the past year covering 21 companies (43.5% of the portfolio).HTEC Aggregate Price Target$30.45High Prediction$30.45Average Prediction$30.45Low Prediction$30.45Holdings in HTEC have an aggregate price target of $30.45 and a range of $30.45 to $30.45 covering 21 companies (43.5% of the portfolio).HTEC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ROBO Global Healthcare Technology and Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 HTEC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.67%ALNYAlnylam Pharmaceuticals$446.51-1.3%4.0011 of 5 stars2.85$405.33 -9.2%26Positive News2.61%AXGNAxoGen$16.14-0.5%2.4366 of 5 stars3.00$26.00 61.1%3News Coverage2.50%STAASTAAR Surgical$27.36-0.1%2.2322 of 5 stars2.00$20.67 -24.5%10Positive News2.34%GHGuardant Health$67.42+4.6%3.2398 of 5 stars3.06$57.50 -14.7%17News CoveragePositive News2.34%MEDPMedpace$475.51+0.5%4.4996 of 5 stars1.93$406.60 -14.5%14News CoveragePositive NewsInsider Trade2.24%AORTArtivion$43.87+0.1%3.2024 of 5 stars3.00$40.63 -7.4%7Insider Trade2.15%TMOThermo Fisher Scientific$493.05+0.7%4.9422 of 5 stars2.73$593.00 20.3%22Positive NewsAnalyst UpgradeInsider Trade2.11%ARWRArrowhead Pharmaceuticals$22.03-1.4%3.6954 of 5 stars3.00$43.14 95.8%9Positive News2.08%CRSPCRISPR Therapeutics$51.83-2.3%3.6071 of 5 stars2.47$71.60 38.1%17Trending NewsAnalyst UpgradeAnalyst Revision2.00%TEMTempus AI$75.86+3.0%1.8698 of 5 stars2.50$67.64 -10.8%12Insider Trade2.00%ADPTAdaptive Biotechnologies$13.18-1.0%2.5342 of 5 stars2.88$12.38 -6.1%8News CoveragePositive News2.00%IQVIQVIA$190.71+1.0%4.892 of 5 stars2.74$228.62 19.9%23News CoveragePositive News1.96%ILMNIllumina$99.96+0.8%4.6374 of 5 stars2.21$123.17 23.2%19Positive News1.94%REGNRegeneron Pharmaceuticals$580.70+0.2%4.7816 of 5 stars2.81$817.67 40.8%27Trending NewsAnalyst Forecast1.88%INCYIncyte$84.61+1.1%4.6283 of 5 stars2.33$81.60 -3.6%18News CoveragePositive News1.85%DHRDanaher$206.09+0.4%4.9174 of 5 stars2.85$247.61 20.1%20Positive News1.83%BSXBoston Scientific$105.56-0.2%4.8627 of 5 stars3.04$117.50 11.3%26Positive News1.81%SYKStryker$391.48+0.5%4.6189 of 5 stars2.79$430.10 9.9%19Positive NewsInsider Trade1.79%BIOBio-Rad Laboratories$298.39+1.6%4.3768 of 5 stars2.60$333.50 11.8%5Positive NewsAnalyst Upgrade1.76%NTRANatera$168.25+0.2%3.0468 of 5 stars3.06$193.19 14.8%18Positive News1.68%PENPenumbra$272.96+0.5%4.8589 of 5 stars2.94$300.47 10.1%18Positive NewsAnalyst Upgrade This page (NYSEARCA:HTEC) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ROBO Global Healthcare Technology and Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ROBO Global Healthcare Technology and Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
